The B2B platform for the best purchasing descision. Identify and compare relevant B2B manufacturers, suppliers and retailers
Close
Filter
Result configuration
Continents
Select continent
Locations
Result types
Company type
Select company type
Industries
Select industry
Company status
Select company status preset
Number of employees
Min.
Max.
Founding year
BIOLOGIX FZCO
Dubai, United Arab Emirates
C
251-500 Employees
2002
Key takeaway
Biologix is a key player in the Middle East/North Africa region, specializing in bringing innovative therapies to market, particularly in rare disease management. Their involvement in conferences focused on value-based care and rare diseases highlights their commitment to advancing therapeutic options.
Reference
Service
Biologix - Expedited Access to Market
Genetrics
Dubai, United Arab Emirates
C
11-50 Employees
2009
Key takeaway
Genetricsinc provides a range of scientific solutions and technologies, which may support in vivo gene therapy research and applications. Their expertise in laboratory systems and bioinformatics could be valuable for advancements in this field.
Reference
Core business
Company – Genetricsinc
Bravo Pharma
Abu Dhabi, United Arab Emirates
C
51-100 Employees
-
Key takeaway
The company, Bravo Pharma, is dedicated to revolutionizing personal health and medical research, with a focus on innovative solutions and personalized medicine, which may align with advancements in in vivo gene therapy. Their commitment to ethical healthcare and cutting-edge technologies underscores their role as a leader in shaping the future of healthtech.
Reference
Core business
Bravopharma
https://www.bravopharma.com/
Looking for more accurate results?
Find the right companies for free by entering your custom query!
25M+ companies
250M+ products
Free to use
Hayat Biotech
Abu Dhabi, United Arab Emirates
C
51-100 Employees
2021
Key takeaway
Hayat Biotech is focused on delivering innovative biotechnological capabilities and has a strong commitment to advancing life sciences. Their experience in providing access to cutting-edge vaccine technology highlights their dedication to addressing health challenges and reducing the risk of infectious diseases.
Reference
Core business
Your Partner in Science + Life - Hayat Biotech
We are Hayat Biotech. Science-led, Technology-based and Human-centric. A joint venture between Sinopharm CNBG and G42.
Genpharm
Dubai, United Arab Emirates
C
11-50 Employees
2012
Key takeaway
The company specializes in market access for niche therapeutics, particularly for rare diseases and specialty care, which may include innovative treatments relevant to in vivo gene therapy. Their strategic partnerships and focus on regulatory and access pathways suggest a commitment to facilitating the availability of cutting-edge therapies in the MENAT region.
Reference
Product
Products - Genpharm
Integrated Gulf Biosystems
Dubai, United Arab Emirates
C
51-100 Employees
1999
Key takeaway
Integrated Gulf Biosystems (IGB) is dedicated to advancing Life Sciences through their focus on Molecular and Genomic solutions, which are essential for translational research and diagnostics related to inherited and infectious diseases. Their extensive portfolio and partnerships with leading companies position them as a key player in the region's clinical genomic landscape.
Reference
Core business
Middle-east, life sciences | Cell Biology | Genome | Protein | DNA | Sequencing | Next Generation Sequencing | Ion Torrent | IGB | Integrated Gulf Biosystems
Integrated Gulf Biosystems (IGB) is a partner of choice for Life Science and Clinical genomic solutions in the Middle East.
Halo Med Group
Dubai, United Arab Emirates
C
11-50 Employees
-
Key takeaway
Halo Med Group offers EXOXE, a cutting-edge solution derived from amniotic fluid exosomes, which is relevant for regenerative medicine and anti-cancer therapies. Their expertise in aesthetic medical equipment and commitment to training ensures that clients can effectively utilize innovative therapies.
Reference
Product
Halo Med Group
Discover EXOXE, the cutting-edge amniotic fluid-derived exosomes for regenerative medicine, skin healing, and anti-cancer therapies.
AstraGene
Dubai, United Arab Emirates
C
11-50 Employees
2020
Key takeaway
AstraGene, UAE's first Molecular Diagnostics Manufacturing company, focuses on producing innovative in-vitro diagnostic reagents and kits. Their commitment to high-quality products and global collaborations positions them as a key player in the field of molecular diagnostics.
Reference
Core business
Home -
Biotech Pharma Services
Al Mu'tarid, United Arab Emirates
C
11-50 Employees
2007
Key takeaway
Biotech Pharma is a pharmaceutical company that focuses on developing and marketing products in various therapeutic areas, including oncology and neurosurgery. With over a decade of experience, they emphasize quality and reliable delivery of medications to healthcare providers in the Middle East.
Reference
Product
neurosurgery - Pharma Services
Gliolan®
NANO IMS | Insurance Management System
Dubai, United Arab Emirates
C
251-500 Employees
2001
Key takeaway
NANO Health is focused on modernizing healthcare systems through advanced digital solutions and innovative research, which can enhance the integration of new therapies and technologies. Their commitment to collaborative intelligence and improved patient outcomes aligns with the goals of in vivo gene therapy.
Reference
Product
NANO Patient Support Program
Technologies which have been searched by others and may be interesting for you:
The In Vivo Gene Therapy industry in the United Arab Emirates presents a unique landscape characterized by several key considerations. Regulatory frameworks are evolving, with the UAE government actively promoting biotechnology and healthcare innovation. Understanding compliance with local regulations and international standards is essential for companies seeking to navigate this sector. Challenges include the need for robust clinical trial infrastructure and skilled workforce, as well as potential ethical concerns surrounding gene editing technologies. Opportunities are abundant, especially with the UAE's strategic investments in healthcare and research initiatives, which aim to position the country as a hub for biotechnology in the region. The competitive landscape is growing, with both local startups and international firms vying for market share, making it crucial for new entrants to differentiate their offerings. Environmental concerns, particularly regarding the long-term impacts of gene therapies, are gaining attention, necessitating responsible practices in research and development. On a global scale, the UAE's commitment to advancing healthcare technologies aligns with wider trends in personalized medicine and gene therapy. This alignment provides a platform for collaboration with international research institutions and companies, thereby enhancing the UAE's relevance in the global gene therapy market. Overall, those interested in this industry should focus on regulatory compliance, market opportunities, and the importance of ethical considerations.
Some interesting numbers and facts about your company results for In Vivo Gene Therapy
Country with most fitting companies | United Arab Emirates |
Amount of fitting manufacturers | 33 |
Amount of suitable service providers | 34 |
Average amount of employees | 51-100 |
Oldest suiting company | 1999 |
Youngest suiting company | 2021 |
Some interesting questions that has been asked about the results you have just received for In Vivo Gene Therapy
What are related technologies to In Vivo Gene Therapy?
Based on our calculations related technologies to In Vivo Gene Therapy are Biomedical (Red), Bioinformatics (Gold), Environmental Biotechnology (Grey), Agricultural Biotechnology (Green), Food Related Biotechnology (Yellow)
Which industries are mostly working on In Vivo Gene Therapy?
The most represented industries which are working in In Vivo Gene Therapy are Healthcare, Pharmaceuticals, IT, Software and Services, Medical, Other
How does ensun find these In Vivo Gene Therapy Companies?
ensun uses an advanced search and ranking system capable of sifting through millions of companies and hundreds of millions of products and services to identify suitable matches. This is achieved by leveraging cutting-edge technologies, including Artificial Intelligence.